186 related articles for article (PubMed ID: 32091426)
1. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Kelly J; Cheng J; Malloy R; Lupi K
J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426
[TBL] [Abstract][Full Text] [Related]
2. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
3. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
[TBL] [Abstract][Full Text] [Related]
6. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.
Nielsen DV; Torp-Pedersen C; Skals RK; Gerds TA; Karaliunaite Z; Jakobsen CJ
Crit Care; 2018 Feb; 22(1):51. PubMed ID: 29482650
[TBL] [Abstract][Full Text] [Related]
8. Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone.
Eaton RE; Kissling KT; Haas GJ; McLaughlin EM; Pickworth KK
Am J Cardiol; 2022 Dec; 184():80-89. PubMed ID: 36167736
[TBL] [Abstract][Full Text] [Related]
9. Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.
Harjai KJ; Mehra MR; Ventura HO; Lapeyre YM; Murgo JP; Stapleton DD; Smart FW
Chest; 1997 Nov; 112(5):1298-303. PubMed ID: 9367472
[TBL] [Abstract][Full Text] [Related]
10. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R; Di Santo P; Jung RG; Marbach JA; Hutson J; Simard T; Ramirez FD; Harnett DT; Merdad A; Almufleh A; Weng W; Abdel-Razek O; Fernando SM; Kyeremanteng K; Bernick J; Wells GA; Chan V; Froeschl M; Labinaz M; Le May MR; Russo JJ; Hibbert B
N Engl J Med; 2021 Aug; 385(6):516-525. PubMed ID: 34347952
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels.
Pan HY; Zhu JH; Gu Y; Yu XH; Pan M; Niu HY
BMC Cardiovasc Disord; 2014 Mar; 14():31. PubMed ID: 24593826
[TBL] [Abstract][Full Text] [Related]
13. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A
ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
[TBL] [Abstract][Full Text] [Related]
15. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
Lowes BD; Tsvetkova T; Eichhorn EJ; Gilbert EM; Bristow MR
Int J Cardiol; 2001 Dec; 81(2-3):141-9. PubMed ID: 11744130
[TBL] [Abstract][Full Text] [Related]
16. Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure.
Scroggins N; Edwards M; Delgado R
Congest Heart Fail; 2005; 11(6):311-4. PubMed ID: 16330906
[TBL] [Abstract][Full Text] [Related]
17. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.
Echols MR; Felker GM; Thomas KL; Pieper KS; Garg J; Cuffe MS; Gheorghiade M; Califf RM; O'Connor CM
J Card Fail; 2006 Dec; 12(9):684-8. PubMed ID: 17174228
[TBL] [Abstract][Full Text] [Related]
20. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z
J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
